ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamacher, J
Right arrow Articles by Nicod, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamacher, J
Right arrow Articles by Nicod, L.
Eur Respir J 1999; 13: 180-186
Copyright © ERS Journals Ltd 1999

Clinical Trial

Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group

J Hamacher, A Spiliopoulos, AM Kurt, and LP Nicod

Pulmonary fungal infection is diagnosed in up to 15-25% of lung transplant recipients and frequently bears a fatal outcome. This prospective uncontrolled study addresses the efficacy and safety of pre-emptive azole therapy against fungal infection in these patients. Fluconazole or itraconazole have been systematically used according to reported fungus sensitivity after the discovery of fungi in lower respiratory tract samples. Patients were treated until the bronchial suture was normal and the cultures of the following bronchoscopy remained negative. Fungi were found post-transplantation in the lower respiratory tract specimens of 26 out of 31 (84%) patients, predominantly Candida albicans (20 patients) and Aspergillus fumigatus (16 patients). Mycelia characteristic of Candida spp. or Aspergillus spp. were found in necrotic tissue at the bronchial suture of nine patients. The mean duration of the 38 treatments was 3.6+/-2.6 months (range, 0.5-12 months). After a median follow-up of 16 (range, 0-48) months, two cases of extended ulcerative and pseudo membranous Aspergillus fumigatus bronchitis were observed and healed under itraconazole treatment. In conclusion, pre-emptive azole therapy may be effective and well-tolerated in lung transplant patients where fungi are found in the airways or pleura.


This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
J. L. Taylor and S. M. Palmer
Critical Care Perspective on Immunotherapy in Lung Transplantation
J Intensive Care Med, December 1, 2006; 21(6): 327 - 344.
[Abstract] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
N. Singh and D. L. Paterson
Aspergillus Infections in Transplant Recipients
Clin. Microbiol. Rev., January 1, 2005; 18(1): 44 - 69.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. F. Shorr, G. M. Susla, and N. P. O'Grady
Pulmonary Infiltrates in the Non-HIV-Infected Immunocompromised Patient: Etiologies, Diagnostic Strategies, and Outcomes
Chest, January 1, 2004; 125(1): 260 - 271.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Helmi, R. B. Love, D. Welter, R. D. Cornwell, and K. C. Meyer
Aspergillus Infection in Lung Transplant Recipients With Cystic Fibrosis: Risk Factors and Outcomes Comparison to Other Types of Transplant Recipients
Chest, March 1, 2003; 123(3): 800 - 808.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L.P. Nicod, J-C. Pache, and N. Howarth
Fungal infections in transplant recipients
Eur. Respir. J., January 1, 2001; 17(1): 133 - 140.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
B. Mehrad, G. Paciocco, F. J. Martinez, T. Clark Ojo, M. D. Iannettoni, and J. P. Lynch III
Spectrum of Aspergillus Infection in Lung Transplant Recipients : Case Series and Review of the Literature
Chest, January 1, 2001; 119(1): 169 - 175.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.